Clinical Scorecard: Case Report Shows Carbimazole's ‘Triple-Hit’

At a Glance

Key Highlights

• Patient developed vasculitis and APS after 15 years of carbimazole treatment
• Rapid stabilization achieved through plasmapheresis
• Disease activity measured with Birmingham Vasculitis Activity Score (BVAS) of 14
• Near-complete resolution of pulmonary hemorrhage post-treatment
• Carbimazole reintroduced without recurrence of vasculitis

Guideline-Based Recommendations

Diagnosis

• Confirm diagnosis with imaging and laboratory evaluation for vasculitis and APS

Management

• Discontinue carbimazole; initiate pulse methylprednisolone and intravenous cyclophosphamide
• Perform plasmapheresis for rapid stabilization

Monitoring & Follow-up

• Monitor disease activity with BVAS and renal function

Risks

• Consider competing risks of hemorrhage and thrombosis in treatment decisions

Patient & Prescribing Data

29-year-old female with hyperthyroidism

Aspirin initiated for APS; systemic anticoagulation deferred due to bleeding risk

Clinical Best Practices

• Rapid initiation of plasmapheresis is critical for stabilization
• Careful monitoring of renal function and disease activity is essential
• Evaluate risks of bleeding and thrombosis when managing APS

References

• Cureus